Bao Ya-Ru, Chen Jing-Wei, Jiang Yan, Wang Lin-Hui, Xue Rong, Qian Jin-Xian, Zhang Guo-Xing
Department of Physiology, Medical College of Soochow University, Suzhou, China.
Department of Internal Medicine, Suzhou TCM Hospital affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Front Pharmacol. 2020 May 21;11:687. doi: 10.3389/fphar.2020.00687. eCollection 2020.
Pulmonary hypertension (PH) remains a prevalent disease globally. Sodium tanshinone II sulfonate A (STS) has been used in clinical treatment of PH.
The aim of the present study was to investigate the effect of sodium STS treatment on hypoxia-induced PH and related mechanisms.
Male Sprague-Dawley rats were housed in a hypoxic chamber with an oxygen concentration of 10 ± 1% for 8 h a day over 21 days. Rats were treated with either STS (low-dose: 10 mg/kg or high-dose: 30 mg/kg) or LY294002 (which is an inhibitor of PI3K). Pulmonary arterial pressure (PAP) was measured, right ventricular hypertrophy parameters were monitored, lung edema parameters were measured, and pathological changes were observed by hematoxylin-eosin (HE) staining. Protein expressions of apoptosis, and PI3K/AKT/mTOR/autophagy pathways in rat lung tissue were examined by western blot. Levels of the pro-inflammatory factors IL-6, IL-8, TNF-α in lung tissues of rats were measured using an enzyme linked immunosorbent assay (ELISA).
Results of our study demonstrate that persistent exposure to hypoxic conditions increased PAP, right ventricular hypertrophy, lung edema, parameters of lung vascular proliferation and decreased the ratio of Bax/Bcl-2. Furthermore, hypoxic conditions activated the PI3K/Akt/mTOR pathway, inhibited autophagy, and elevated abundance of inflammatory factors in rat lung tissue. Treatment with STS resulted in a dose-dependent decrease in PAP, right ventricular hypertrophy, lung edema, lung vascular proliferation and reversed hypoxia induced lung tissue protein expression and pro-inflammatory factors in rat lung tissue. In addition, hypoxia-induced increases in PAP, cardiac hypertrophy, and lung expression of the proteins PI3K/Akt/mTOR/autophagy pathway were partially reversed by treatment with LY294002.
STS alleviates hypoxia-induced PH by promoting apoptosis, inhibiting PI3K/AKT/mTOR pathway, up-regulating autophagy, and inhibiting inflammatory responses.
肺动脉高压(PH)在全球范围内仍然是一种普遍存在的疾病。丹参酮 IIA 磺酸钠(STS)已用于 PH 的临床治疗。
本研究旨在探讨 STS 治疗对缺氧诱导的 PH 的影响及其相关机制。
将雄性 Sprague-Dawley 大鼠置于氧浓度为 10±1%的缺氧舱中,每天 8 小时,持续 21 天。大鼠分别接受 STS(低剂量:10mg/kg 或高剂量:30mg/kg)或 LY294002(一种 PI3K 抑制剂)治疗。测量肺动脉压(PAP),监测右心室肥大参数,测量肺水肿参数,并通过苏木精-伊红(HE)染色观察病理变化。通过蛋白质印迹法检测大鼠肺组织中凋亡以及 PI3K/AKT/mTOR/自噬途径的蛋白表达。使用酶联免疫吸附测定(ELISA)测量大鼠肺组织中促炎因子 IL-6、IL-8、TNF-α 的水平。
我们的研究结果表明,持续暴露于缺氧条件会增加 PAP、右心室肥大、肺水肿、肺血管增殖参数,并降低 Bax/Bcl-2 比值。此外,缺氧条件激活了 PI3K/Akt/mTOR 途径,抑制了自噬,并提高了大鼠肺组织中炎症因子的丰度。STS 治疗导致 PAP、右心室肥大、肺水肿、肺血管增殖呈剂量依赖性降低,并逆转了缺氧诱导的大鼠肺组织蛋白表达和促炎因子。此外,LY294002 治疗部分逆转了缺氧诱导的 PAP、心脏肥大以及肺组织中 PI3K/Akt/mTOR/自噬途径蛋白的表达增加。
STS 通过促进凋亡、抑制 PI3K/AKT/mTOR 途径、上调自噬和抑制炎症反应来减轻缺氧诱导的 PH。